Form D · Biotechnology
BIOFLIGHT, LLC
Akron, OH · CIK 0001838721
Offering snapshot reported May 3, 2022 · SEC filing
- Reported sold
- $400K Offering amount: $2.4M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jan 19, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 3, 2022 | Initial | $400,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-444276
Source: Form D, filed May 3, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Shorten | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
528 S. Main Street, Suite 813 B
Akron, OH, 44311
Akron, OH, 44311